| Gene symbol | WT1 | Synonyms | AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1, WT33 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11p13 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | WT1 transcription factor | ||||
| GTO ID | GTC1375 |
| Trial ID | NCT01291420 |
| Disease | Breast Cancer | Malignant Mesothelioma | Colorectal Cancer | Sarcoma | Glioblastoma | Renal Cell Carcinoma |
| Altered gene | WT1 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | RNA-modified dendritic cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | Therapeutic Efficacy of Wilms' Tumor Gene (WT1) mRNA-electroporated Autologous Dendritic Cell Vaccination in Patients With Solid Tumors: a Phase I/Feasibility Study |
| Year | 2010 |
| Country | Belgium |
| Company sponsor | University Hospital, Antwerp |
| Other ID(s) | CCRG 11-001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||